| Market Cap | 83,093 |
|---|---|
| Day Change | 0.0177 (63.67%) |
| Volume | 212,405 |
| Avg Volume | 34,998.462 |
| Price Range | 0.0188-0.0455 |
| Country | US |
|---|---|
| Sector | Healthcare |
| Industry | Biotechnology |
| Exchange | NASDAQ |
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
| 52 Week High | 0.085 |
|---|---|
| 52 Week High Date | 2025-02-25 |
| 52 Week Low | 0.01 |
| 52 Week Low Date | 2025-07-08 |
| 10D Avg Trading Vol | 0.05976 |
| YTD Price Return Daily | 7.3359 |
| MTD Price Return Daily | 62.5731 |